Insider · CIK 0001367451
Caroline M Loewy
Files at CBAY (CymaBay Therapeutics, Inc.), EFTR (eFFECTOR Therapeutics, Inc.), CERO (CERO THERAPEUTICS HOLDINGS, INC.). First filing -, latest -.
In brief
Caroline M Loewy files SEC Form 4 as director at CBAY (CymaBay Therapeutics, Inc.), and also at EFTR (eFFECTOR Therapeutics, Inc.), CERO (CERO THERAPEUTICS HOLDINGS, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Caroline M Loewy has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 14 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 13, 2024 | EFTR eFFECTOR Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +800 | $0.00 | $0 | 800 | Jun 13, 2024 |
| Mar 22, 2024 | CBAY CymaBay Therapeutics, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -30,000 | - | - | 0 | Mar 22, 2024 |
| Mar 22, 2024 | CBAY CymaBay Therapeutics, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -15,000 | - | - | 0 | Mar 22, 2024 |
| Mar 22, 2024 | CBAY CymaBay Therapeutics, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -7,500 | - | - | 0 | Mar 22, 2024 |
| Mar 22, 2024 | CBAY CymaBay Therapeutics, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -16,000 | - | - | 0 | Mar 22, 2024 |
| Mar 22, 2024 | CBAY CymaBay Therapeutics, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -27,705 | - | - | 0 | Mar 22, 2024 |
| Mar 22, 2024 | CBAY CymaBay Therapeutics, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -49,245 | - | - | 0 | Mar 22, 2024 |
| Mar 22, 2024 | CBAY CymaBay Therapeutics, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -32,000 | - | - | 0 | Mar 22, 2024 |
| Mar 22, 2024 | CBAY CymaBay Therapeutics, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -67,000 | - | - | 0 | Mar 22, 2024 |
| Mar 22, 2024 | CBAY CymaBay Therapeutics, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -25,000 | - | - | 0 | Mar 22, 2024 |
| Mar 22, 2024 | CBAY CymaBay Therapeutics, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -14,010 | - | - | 0 | Mar 22, 2024 |
| Feb 19, 2024 | EFTR eFFECTOR Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +2,000 | $0.00 | $0 | 2,000 | Feb 21, 2024 |
| Feb 14, 2024 | CERO CERO THERAPEUTICS HOLDINGS, INC. | JOther Class A Common Stock | +5,828 | - | - | 5,828 | Feb 16, 2024 |
| Jan 24, 2024 | CBAY CymaBay Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +14,010 | $0.00 | $0 | 14,010 | Jan 26, 2024 |
Questions about Caroline M Loewy
Answered from the filings on this page, as of the latest one.
Is Caroline M Loewy buying or selling?
Caroline M Loewy has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Caroline M Loewy's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Caroline M Loewy has 0.
Where does Caroline M Loewy file Form 4?
Caroline M Loewy has filed Form 4 at CBAY (CymaBay Therapeutics, Inc.); EFTR (eFFECTOR Therapeutics, Inc.); CERO (CERO THERAPEUTICS HOLDINGS, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.